DEPOMED INC's ticker is DEPO and the CUSIP is 249908104. A total of 209 filers reported holding DEPOMED INC in Q2 2015. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $110,886,000 | -17.6% | 6,153,509 | +14.2% | 0.02% | -28.6% |
Q3 2016 | $134,489,000 | +35.4% | 5,386,035 | +6.4% | 0.03% | +27.3% |
Q2 2016 | $99,350,000 | +50.6% | 5,063,688 | +7.0% | 0.02% | +46.7% |
Q1 2016 | $65,953,000 | -19.7% | 4,734,625 | +4.4% | 0.02% | -21.1% |
Q4 2015 | $82,183,000 | -7.3% | 4,532,964 | -3.6% | 0.02% | -17.4% |
Q3 2015 | $88,616,000 | -16.0% | 4,701,115 | -4.4% | 0.02% | -8.0% |
Q2 2015 | $105,497,000 | -4.1% | 4,915,971 | +0.2% | 0.02% | -3.8% |
Q1 2015 | $109,969,000 | +46.4% | 4,907,144 | +5.2% | 0.03% | +36.8% |
Q4 2014 | $75,133,000 | +15.4% | 4,663,758 | +8.8% | 0.02% | +5.6% |
Q3 2014 | $65,115,000 | +78.7% | 4,286,684 | +63.5% | 0.02% | +80.0% |
Q2 2014 | $36,441,000 | -6.9% | 2,621,621 | -2.8% | 0.01% | -16.7% |
Q1 2014 | $39,128,000 | +40.5% | 2,698,488 | +2.5% | 0.01% | +50.0% |
Q4 2013 | $27,852,000 | +68.5% | 2,632,542 | +19.0% | 0.01% | +33.3% |
Q3 2013 | $16,527,000 | +52.3% | 2,212,501 | +14.6% | 0.01% | +50.0% |
Q2 2013 | $10,849,000 | – | 1,930,384 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DELTEC ASSET MANAGEMENT LLC | 2,252,402 | $31,376,000 | 7.88% |
Healthcare Value Capital, LLC | 350,000 | $4,876,000 | 7.16% |
Senvest Management, LLC | 4,977,256 | $69,333,000 | 5.82% |
Consonance Capital Management LP | 2,756,360 | $38,396,000 | 5.81% |
Opaleye Management Inc. | 325,000 | $4,527,000 | 2.82% |
Krensavage Asset Management, LLC | 447,000 | $6,227,000 | 2.23% |
Healthcare Value Capital, LLC | 100,000 | $1,393,000 | 2.05% |
Starboard Value LP | 2,950,000 | $41,094,000 | 1.44% |
HealthInvest Partners AB | 200,000 | $2,786,000 | 1.30% |
OAK RIDGE INVESTMENTS LLC | 7,206,286 | $100,384,000 | 1.29% |